Interaction of Cyclophosphamide and Ketamine in vivo

NeuroImmunoModulation

Volumn 3, Issue 6, 1996, Pages 333-335

  Rojavin, Mikhail A ^a   Tsygankov, Alexander Y ^b   Ziskin, Marvin C ^a  

^a Richard J Fox Ctr Biomed Phys   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anesthesia; Cyclophosphamide; Ketamine; Mice BALB c; Peritoneal macrophages; T cells

Indexed keywords

ANESTHETIC AGENT; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; KETAMINE;

ANESTHESIA; ANESTHESIA MECHANISM; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CANDIDA ALBICANS; CELLULAR IMMUNITY; CONTROLLED STUDY; IMMUNOSUPPRESSIVE TREATMENT; INTRAPERITONEAL DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; T LYMPHOCYTE;

ANESTHESIA; ANESTHETICS, DISSOCIATIVE; ANIMALS; CYCLOPHOSPHAMIDE; DRUG INTERACTIONS; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; IMMUNOSUPPRESSIVE AGENTS; KETAMINE; MALE; MICE; MICE, INBRED BALB C; SPLEEN; T-LYMPHOCYTES; TIME FACTORS;

EID: 12644306863     PISSN: 10217401     EISSN: 14230216     Source Type: Journal    
DOI: 10.1159/000097364     Document Type: Article

References (12)

1. Ueno Y, Kohgo Y, Sakamaki S, Itoh Y, Taka-hashi M, Hirayama Y. Niitsu Y: Immuno-chemotherapy in B-16-melanoma-cell-trans-planted mice with combinations of inlerleukin-2, cyclophosphamide, and PSK. Oncology 1994;41:296-302.
2. Krawczyk CM, Verstovcck S, Ujhazy P, Mac-cubbin D, Ehrke MJ; Protective specific immunity induced by cyclophosphamide plus tumor necrosis factor alpha combination treatment of EL4-Iymphoma-bcaring C57BL/6 mice. Cancer Immunol Immunother 1995;40:347-357.
3. Lasek W, Sora M, Wankowicz A, Jakobisiak M: Combination of immunotherapy with cy-clophosphamidc/actinomycin D chemotherapy potentiates antileukemic effect and reduces the toxicity in a LI2210 leukemia model in mice. Cancer Lett 1995;99:137-143.
4. Lockwood LL, Silbert LH, Laudenslager ML, Watkins LR, Maier SF: Anesthesia-induced modulation of in vivo antibody levels: A study of pentobarbital, chloral hydrate, methoxy-flurane. halolhane, and kelaminc/xylazine. Anesth Analg 1993;77:769-774.
5. Krumholz W, Endrass J, Hempelmann G: Inhibition of phagocytosis and killing of bacteria by anaesthetic agents in vitro. Br J Anaesth 1995:75:66-70.
6. Davidson JA, Boom SJ, Pearsall FJ. Zhang P, Ramsay G: Comparison of the effects of four i.v. anaesthetic agents on polymorphonuclear leucocyte function. Br J Anaesth 1995:74:315-318.
7. Toyota S, Moriyama M, Otake T, Kono J, Shu-dou Y, Satake T, Seki K., Masuda S. Amaki Y: Effect of anaesthetic agents on the phagocytic function of human polymorphonuclear leucocytes through analysis with a phagocytic plaque method. Inflam Res 1995;44:204-206.
8. Duricux ME: Inhibition by ketamine of muscarinic acetylcholine receptor. Ancslh Analg 1995:81:57-62.
9. Vcrma A, Moghaddam B: NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine. J Neurosci 1996;16:373-379.
10. Galley HF, Nelson LR, Webster NR: Anaesthetic agents decrease the activity of nitric oxide synthase from human polymorphonuclear leucocytes. Br J Anaesth 1995:75:326-329.
11. Lin SZ, Chiou AL, Wang Y: Ketamine antagonizes nitric oxide release from cerebral cortex after middle cerebral artery ligation in rats. Stroke 1996;27:747-752.
12. Krumholz W, Demel C. Jung S. Meuthen G, Knecht J, Hcmpelmann G: The effects of thiopentone, etomidate, ketamine and midazolam on several bactericidal functions of polymorphonuclear leucocytes in vitro. Eur J Anaesthe-siol 1995;12:141-146.